Linda Neuman
Nessuna posizione attualmente
Patrimonio netto: 5 195 $ in data 30/04/2024
Profilo
Linda Neuman held several positions in the pharmaceutical industry, including Medical Director at Onyx Pharmaceuticals, Senior Medical Director at Puma Biotechnology, and Vice President of Clinical Development at Sunesis Pharmaceuticals and Catalyst Biosciences.
She also served as Chief Medical Officer at Adverum Biotechnologies and Spyre Therapeutics.
Dr. Neuman holds a Doctorate degree from Siu School of Medicine, an undergraduate degree from Southern Illinois University, and an MBA from Indiana Wesleyan University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SPYRE THERAPEUTICS, INC
0.00% | 23/02/2023 | 160 ( 0.00% ) | 5 195 $ | 30/04/2024 |
Precedenti posizioni note di Linda Neuman
| Società | Posizione | Fine |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 14/04/2023 |
| CATALYST BIOSCIENCES | Direttore Tecnico/Scientifico/R&S | 01/04/2021 |
| ADVERUM BIOTECHNOLOGIES, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2018 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
| PUMA BIOTECHNOLOGY, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Linda Neuman
| Indiana Wesleyan University | Masters Business Admin |
| Southern Illinois University | Undergraduate Degree |
| Siu School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Linda Neuman
